iDose TR Postoperative Success

Show Description +

Savak Teymoorian, MD, MBA, shares his approach to examining patients after iDose TR implantation, highlighting how to check for correct placement of the implant and confirm its efficacy.

Posted: 1/17/2025

Keywords:

iDose TR

Up Next

iDose TR & Interventional Glaucoma

Savak “Sev” Teymoorian, MD, MBA


Glaucoma

Interventional Glaucoma: Practice Assessments, Insights, and Driving Towards a Consensus-Based Approach to Treating Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Evolution of the Interventional Glaucoma Mindset

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Re-Evaluating the Conventional Glaucoma Treatment Journey

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Nonadherence or Noncompliance Challenges in Glaucoma Management

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Evaluating Risk of Topical Drops Versus Early Procedural Intervention

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Innovative Interventional Glaucoma Technologies

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Incorporating iDose TR

Savak “Sev” Teymoorian, MD, MBA

Patient Education for iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR Patient Selection

Savak “Sev” Teymoorian, MD, MBA

iDose TR: An Interventional Mindset

Savak “Sev” Teymoorian, MD, MBA

iDose TR: A Patient’s Perspective

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Outcomes

Savak “Sev” Teymoorian, MD, MBA

Making Patients Comfortable With iDose TR

Savak “Sev” Teymoorian, MD, MBA

iDose TR: Day of Procedure

Savak “Sev” Teymoorian, MD, MBA

iDose TR Postoperative Success

Savak “Sev” Teymoorian, MD, MBA

iDose TR & Interventional Glaucoma

Savak “Sev” Teymoorian, MD, MBA

Patient Identification for iDose TR®

Savak Teymoorian, MD, MBA; John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; and Lorraine M. Provencher, MD

Live Demonstration: iDose TR® Implantation

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

iDose TR® Live Procedure Broadcast

John Berdahl, MD; Iqbal Ike K. Ahmed, MD, FRCSC; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

Expert Panel iDose TR® Q&A Session

Iqbal Ike K. Ahmed, MD, FRCSC; John Berdahl, MD; Lorraine M. Provencher, MD; and Savak Teymoorian, MD, MBA

Shatter the Status Quo: Introducing iDose® TR

Ike Ahmed, MD, FRCSC; I. Paul Singh, MD; Mark J. Gallardo, MD; Jason Bacharach, MD; and Sahar Bedrood, MD, PhD

Clinical Data From iDose® TR

Jason Bacharach, MD

Advancing Interventional Glaucoma

Sahar Bedrood, MD, PhD

A Glaucoma Treatment Revolution With iStent infinite®

Deborah Ristvedt, DO; and Manjool Shah, MD

Elegantly Precise Microsurgery With iStent infinite®

Deborah Ristvedt, DO; and Manjool Shah, MD

Live Surgery Demonstration of iStent infinite®

Blake K. Williamson, MD, MPH, MS; Manjool Shah, MD; and Deborah Ristvedt, DO

Defining Success With Interventional Glaucoma

Blake K. Williamson, MD, MPH, MS; Manjool Shah, MD; and Deborah Ristvedt, DO

iStent Infinite® Live Surgery Broadcast

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Interventional Glaucoma

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

The iStent Infinite®

Sahar Bedrood, MD, PhD; and I. Paul Singh, MD

iStent Infinite® Surgery

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Defining a Treatment Algorithm

Inder Paul Singh, MD; and Sahar Bedrood, MD, PhD

iAccess Trabecular Trephine

Blake Williamson, MD, MPH, MS

Stenting and Microgoniotomy

Inder Paul Singh, MD

iAccess Microgoniotomy

Inder Paul Singh, MD

iStent inject in My Practice

Sahar Bedrood, MD, PhD

An Overview of the iStent inject

Blake K. Williamson, MD, MPH, MS

Why I Choose the iStent inject?

John A. Hovanesian MD

The Learning Curve

Elizabeth Yeu, MD

MIGS and Your Practice

Arsham Sheybani, MD

Safety of the iStent

Arsham Sheybani, MD

Working With a Referral Base

Arsham Sheybani, MD

iStent Learning Curve

Tal Raviv, MD

The iStent Procedure

Arsham Sheybani, MD

Safety of the iStent

Tal Raviv, MD

The iStent Journey

Kerry Solomon, MD

Surgical Outcomes

Elizabeth Yeu, MD

MIGS Economics 101

Matt Jensen

Cases That Catch Your Eye

Steven Sarkisian, MD

Raising the Outcomes Bar

Robert Cionni, MD

The iStent Premium Package

Jeffrey Whitman, MD

Efficacy With the iStent

I. Paul Singh, MD

Why iStent

David Goldman MD, Thomas Samuelson, MD

Surgical Pearls

David Goldman MD, Thomas Samuelson, MD

Data Review

David Goldman MD, Thomas Samuelson, MD

Practice Success

David Goldman MD, Thomas Samuelson, MD

MIGS: Glaukos iStent User Group: Surgical Approach to MIGS

Ike K. Ahmed MD, L. Jay Katz MD, Richard A. Lewis MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 7

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 6

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 5

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 4

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 3

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 2

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Case Studies - Part 1

John Berdahl, MD, Kerry D. Solomon MD, Thomas W. Samuelson MD

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 5

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 4

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 3

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 2

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

MIGS: Glaukos iStent User Group: Incorporating iStent into Your Practice - Part 1

Eric D. Donnenfeld MD, Kerry D. Solomon MD, Stephen G. Slade MD, FACS

Corneal Health

Drafting Your Keratoconus Quarterback

Brandon D. Ayres, MD; and Priya M. Mathews, MD, MPH

Optimizing Your Keratoconus Management Playbook

Brandon D. Ayres, MD; and Eva Kim, MD

Establish a Game Plan for Treating Bilateral Keratoconus

Brandon D. Ayres, MD; and John Berdahl, MD

Use Your Dream Team to Execute Your Keratoconus Strategy

Brandon D. Ayres, MD; Susan DeGroot, MBA; and Vivian Cole, BA

iDose TR Postoperative Success

Savak Teymoorian, MD, MBA, shares his approach to examining patients after iDose TR implantation, highlighting how to check for correct placement of the implant and confirm its efficacy.

Posted: 1/17/2025

Keywords:

iDose TR

Resources

New Surgical Technologies to Expand Your Treatment Algorithm

View Resource

iStent: A Powerful, Predictable, and Proven Technology

View Resource

Maximize Efficacy Minimize Concerns

Read Supplement

Why I Choose the iStent Inject

Read Supplement

Matching Glaucoma Patient Needs With the Right Procedure

Read Supplement

Choosing iStent for the Refractive Cataract Practice

Read Supplement

Goals of Treating Glaucoma During Cataract Surgery

Read Supplement